Your fact-checks will appear here
Changes to prescription drug negotiation rules and their impact on healthcare spending
enacted and began implementing laws and policies that lower prescription drug costs for many Americans, particularly people with , chiefly through ’s negotiation authority, an inflation rebate program...
Across multiple recent election cycles the pharmaceutical industry has shifted from a historical Republican tilt to a more hedged or Democratic-leaning pattern: industry PACs and employees gave more t...
is being promoted by as delivering steep cuts to the cash price of weight‑loss drug —dropping advertised monthly list prices from roughly $1,086 to averages near $346 and lows of $299 for self‑pay cus...
The reporting shows a consistent pattern in 2024 of pharmaceutical PACs directing sizeable, targeted donations to crucial lawmakers — including senators positioned to influence Medicare drug-pricing p...
Large pharmaceutical and health product industry spending—billions on lobbying and hundreds of millions on campaign contributions over recent decades—has been a persistent force shaping U.S. health po...